Articles with public access mandates - Leon WorthLearn more
Not available anywhere: 15
Risks, severity and timing of infections in patients with multiple myeloma: a longitudinal cohort study in the era of immunomodulatory drug therapy
BW Teh, SJ Harrison, LJ Worth, T Spelman, KA Thursky, MA Slavin
British journal of haematology 171 (1), 100-108, 2015
Mandates: National Health and Medical Research Council, Australia
Infections in patients with chronic lymphocytic leukaemia: mitigating risk in the era of targeted therapies
BW Teh, CS Tam, S Handunnetti, LJ Worth, MA Slavin
Blood reviews 32 (6), 499-507, 2018
Mandates: National Health and Medical Research Council, Australia
Epidemiology of bloodstream infections in patients with myeloma receiving current era therapy
BW Teh, SJ Harrison, MA Slavin, LJ Worth
European journal of haematology 98 (2), 149-153, 2017
Mandates: National Health and Medical Research Council, Australia
Consensus guidelines for optimising antifungal drug delivery and monitoring to avoid toxicity and improve outcomes in patients with haematological malignancy and haemopoietic …
MM Chau, K Daveson, JWC Alffenaar, A Gwee, SA Ho, DJE Marriott, ...
Internal Medicine Journal 51, 37-66, 2021
Mandates: National Health and Medical Research Council, Australia
Prevention of viral infections in patients with multiple myeloma: the role of antiviral prophylaxis and immunization
BW Teh, MA Slavin, SJ Harrison, LJ Worth
Expert review of anti-infective therapy 13 (11), 1325-1336, 2015
Mandates: National Health and Medical Research Council, Australia
Consensus guidelines for antifungal stewardship, surveillance and infection prevention, 2021
A Khanina, SY Tio, MR Ananda‐Rajah, SE Kidd, E Williams, L Chee, ...
Internal medicine journal 51, 18-36, 2021
Mandates: National Health and Medical Research Council, Australia
Establishing essential metrics for antifungal stewardship in hospitals: the results of an international Delphi survey
A Khanina, KF Urbancic, GM Haeusler, DCM Kong, AP Douglas, SY Tio, ...
Journal of Antimicrobial Chemotherapy 76 (1), 253-262, 2021
Mandates: National Health and Medical Research Council, Australia
High rates of proven invasive fungal disease with the use of ibrutinib monotherapy for relapsed or refractory chronic lymphocytic leukemia
BW Teh, W Chui, S Handunnetti, C Tam, LJ Worth, KA Thursky, MA Slavin
Leukemia & lymphoma 60 (6), 1572-1575, 2019
Mandates: National Health and Medical Research Council, Australia
Pilot study of a combined genomic and epidemiologic surveillance program for hospital-acquired multidrug-resistant pathogens across multiple hospital networks in Australia
NL Sherry, RS Lee, CL Gorrie, JC Kwong, RL Stuart, TM Korman, ...
Infection Control & Hospital Epidemiology 42 (5), 573-581, 2021
Mandates: US National Institutes of Health, National Health and Medical Research …
Introduction to the updated A ustralian and N ew Z ealand consensus guidelines for the use of antifungal agents in the haematology/oncology setting, 2014
MA Slavin, KA Thursky, LJ Worth, CC Chang, CO Morrissey, CC Blyth, ...
Internal Medicine Journal 44 (12b), 1267-1276, 2014
Mandates: National Health and Medical Research Council, Australia
[18F] FDG-PET-CT compared with CT for persistent or recurrent neutropenic fever in high-risk patients (PIPPIN): a multicentre, open-label, phase 3, randomised, controlled trial
A Douglas, K Thursky, T Spelman, J Szer, A Bajel, S Harrison, SY Tio, ...
The Lancet Haematology 9 (8), e573-e584, 2022
Mandates: National Health and Medical Research Council, Australia
A randomized trial of two 2-dose influenza vaccination strategies for patients following autologous hematopoietic stem cell transplantation
BW Teh, VKY Leung, FL Mordant, SG Sullivan, T Joyce, SJ Harrison, ...
Clinical Infectious Diseases 73 (11), e4269-e4277, 2021
Mandates: National Health and Medical Research Council, Australia, UK Medical Research …
Consensus guidelines for improving patients' understanding of invasive fungal disease and related risk prevention in the haematology/oncology setting, 2021
SS Fernando, EK Paige, C Dendle, R Weinkove, DCM Kong, P Omond, ...
Internal Medicine Journal 51, 220-233, 2021
Mandates: National Health and Medical Research Council, Australia
Performance of a hospital-acquired complication algorithm using administrative data for detection of central line-associated bloodstream infections: experience at an Australian …
M Herson, SJ Curtis, G Land, AJ Stewardson, LJ Worth
Journal of Hospital Infection 112, 116-118, 2021
Mandates: National Health and Medical Research Council, Australia
Identifying Methicillin-resistant Staphylococcus aureus Colonization or Infection Using Administratively Coded Data
L Lim, LJ Worth, A Bull
Clinical Infectious Diseases 77 (2), 331-332, 2023
Mandates: US National Institutes of Health
Available somewhere: 25
Impact of an integrated antibiotic allergy testing program on antimicrobial stewardship: a multicenter evaluation
JA Trubiano, KA Thursky, AJ Stewardson, K Urbancic, LJ Worth, ...
Clinical Infectious Diseases 65 (1), 166-174, 2017
Mandates: US National Institutes of Health, National Health and Medical Research …
Consensus guidelines for optimising antifungal drug delivery and monitoring to avoid toxicity and improve outcomes in patients with haematological malignancy, 2014
MM Chau, DCM Kong, SJ Van Hal, K Urbancic, JA Trubiano, ...
Internal medicine journal 44 (12b), 1364-1388, 2014
Mandates: National Health and Medical Research Council, Australia
Invasive fungal infections in patients with multiple myeloma: a multi-center study in the era of novel myeloma therapies
BW Teh, JC Teng, K Urbancic, A Grigg, SJ Harrison, LJ Worth, MA Slavin, ...
Haematologica 100 (1), e28, 2015
Mandates: National Health and Medical Research Council, Australia
Improving antimicrobial stewardship by antibiotic allergy delabeling: evaluation of knowledge, attitude, and practices throughout the emerging infections network
JA Trubiano, SE Beekmann, LJ Worth, PM Polgreen, KA Thursky, ...
Open forum infectious diseases 3 (3), ofw153, 2016
Mandates: US National Institutes of Health, National Health and Medical Research …
Infection risk with immunomodulatory and proteasome inhibitor–based therapies across treatment phases for multiple myeloma: A systematic review and meta-analysis
BW Teh, SJ Harrison, LJ Worth, KA Thursky, MA Slavin
European Journal of Cancer 67, 21-37, 2016
Mandates: National Health and Medical Research Council, Australia
Publication and funding information is determined automatically by a computer program